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Neuroimaging has greatly enhanced the cognitive neuroscience understanding of the human brain and its
variation across individuals (neurodiversity) in both health and disease. Such progress has not yet, however,
propelled changes in educational or medical practices that improve people’s lives. We review neuroimaging
findings in which initial brain measures (neuromarkers) are correlated with or predict future education,
learning, and performance in children and adults; criminality; health-related behaviors; and responses to
pharmacological or behavioral treatments. Neuromarkers often provide better predictions (neuroprognosis),
alone or in combination with other measures, than traditional behavioral measures. With further advances in
study designs and analyses, neuromarkers may offer opportunities to personalize educational and clinical
practices that lead to better outcomes for people.Noninvasive neuroimaging has provided remarkable new in-
sights into human brain structure and function in both health
and disease. For over a century, understanding the human brain
depended on naturally occurring brain injuries or unexpected
consequences of neurosurgeries. From clinical cases such as
Leborgne, Phineas Gage, H.M., and commissurotomy patients,
we gleaned insights, respectively, into the roles of the left pre-
frontal cortex in language (Broca, 1861), the ventral prefrontal
cortex in decision-making and social behavior (Harlow, 1868),
the medial temporal lobe in memory (Scoville and Milner,
1957), and functional asymmetries between the cerebral hemi-
spheres (Gazzaniga, 1970). Noninvasive neuroimaging has
permitted a second wave of discoveries about the brain that
has expanded the horizon of human neuroscience with examina-
tion of typical functions across many domains of the human
mind, from perception and cognition to emotion, social and
moral thought, and economic decision-making. Furthermore,
such imaging has offered the first compelling evidence that
neuropsychiatric and neurodevelopmental disorders reflect
fundamental differences in brain structure and function.
Uniquely, neuroimaging has revealed not only universal princi-
ples of functional brain organization but also neurodiversity:
how such brain functions vary across people in relation to age,
sex, personality, culture, and genetics. Here we review the prog-
ress in a novel application of neuroimaging: the use of such
measureable neurodiversity to predict future human behavior.
Such prediction may constitute a humanitarian and pragmatic
contribution of human cognitive neuroscience to society, but
this contribution will require rigorous science and also ethical
considerations.
Neuroscientists, psychologists, and physicians are contem-
plating how human neuroimaging may best inform basic and
clinical research. For basic research, there is discussion aboutwhether neuroimaging has informed cognitive theories beyond
the mapping of psychological functions to neural networks
(e.g., Mather et al., 2013). For clinical research, it is noteworthy
that the 2013 revision of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5), the defining document of diag-
nosis from the American Psychiatric Association, was little, if at
all, influenced by the over 15,000 MRI studies of psychiatric dis-
orders listed in PubMed (and this does not include studies using
other methods, such as electroencephalography (EEG), magne-
toencephalography (MEG), or positron emission tomography
(PET)). Remarkable advances in genetics have also had little
practical influence as yet on diagnosis or treatment of psychiatric
disorders. Because psychiatric disorders are known to be herita-
ble, and because these disorders must have a brain basis, it is
likely that progress in genetics and neuroimaging will illuminate
such disorders in the long run. Here we consider how neuroi-
maging may contribute to helping people in the nearer future.
This review focuses on structural and functional neuroimaging
and considers findings in which an initial brain measure (a neuro-
marker) is associated with a future behavioral outcome. Some
studies relate neuromarkers to individual differences in later
perceptual or cognitive performance among typical or healthy
people and have relevance for education and training. Other
studies relate neuromarkers to individual differences among
patients with a given diagnosis to future clinical status or
response to treatment (neuroprognosis) and have relevance for
neuropsychiatric disorders.
Such correlational or predictive studies differ from other kinds
of studies in two main ways. First, in the case of group studies
(e.g., comparison of patient and control groups), neuroimaging
differences aremost pronounced when there is greater homoge-
neity of a brain measure within each group so that groups are
statistically separable. Conversely, greater heterogeneity of aNeuron 85, January 7, 2015 ª2015 Elsevier Inc. 11
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that correlate with variable outcomes. Second, for studies that
examine response to treatment, individual differencesmay delin-
eate not the neural systems most affected by the disorder but,
rather, heterogeneity among patients in the neural systems
that are most important and variable for how a treatment yields
benefits. For example, if a behavioral therapy helps a patient
with a disorder to learn how to regulate thoughts or emotions,
then the neuromarkers associated with treatment response
may be in neural networks that support such learning rather
than in networks related to the etiology or progression of the dis-
order.
Neuroimaging Measures
Noninvasive neuroimaging measures provide indices of human
brain structure and function that vary in their strengths and limi-
tations. This review focuses on measures that maximize spatial
information, specifically MRI-derived measures. Brain structure
can be quantified by measuring volume, thickness, or density
(voxel-based morphometry [VBM]). Microstructural properties
of white matter pathways can be characterized by diffusion
tensor imaging (DTI). Brain functions can be quantified via fMRI
by activation studies that correlate experimental conditions or
behavioral performance with neural activity, as indexed by
changes in blood oxygenation level-dependent (BOLD) signals.
During a resting state with no task or stimuli, there are sponta-
neous fluctuations in functionally related brain regions that corre-
late with one another, and the patterns of these correlations may
reveal intrinsic functional relations of brain regions (Biswal et al.,
1995). Resting-state fMRI, EEG, and MEG can elucidate these
networks. Because it measures hemodynamic response, fMRI
is inherently poor in temporal resolution, whereas EEG and
MEG provide high temporal resolution (at the loss of spatial res-
olution).
For applications in education or medicine, there is a trade-off
between measures that are task-dependent (activation fMRI,
MEG, and EEG) versus measures that are task-independent
(structural MRI and DTI, fMRI, MEG, and EEG resting state).
On one hand, tasks can selectively invoke brain responses to
salient stimuli (e.g., to print in children with reading difficulty or
to sad facial expressions in depression). The advantage of this
approach is that tasks and stimuli can be tailored to specifically
assay salient mental operations. On the other hand, such tasks
demand participant performance that can result in behavioral
confounds, vary in design from study to study, and have not typi-
cally been developed to maximize reliability of measurement. In
contrast, structural and resting state measures can be acquired
in a consistent fashion, have promise for reliability (e.g., Shehzad
et al., 2009; Wonderlick et al., 2009; Vollmar et al., 2010), can
accommodate a broad range of participants (including infants),
and are independent of task performance in the scanner.
Analytic Approaches: FromCorrelation to Individualized
Prediction
An ultimate goal of the use of neuromarkers for neuroprognosis
is to perform individualized predictions of educational or health
outcomes.Most studies to date have related variation in baseline
brain measures to variation in subsequent outcomes. Given that12 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.such analyses hinge on knowledge of the outcomes, such ana-
lyses could be described more as postdiction than prediction
(Whelan and Garavan, 2014). However, if neuromarkers are to
become useful in practice, they must predict outcomes for
new individuals based on models developed previously with
other individuals. A cognitive neuroscience of prediction, there-
fore, needs to build on theory and methods that allow for effec-
tive creation, evaluation, and selection of prediction models
(Pereira et al., 2009).
The term prediction is used in three different ways in relevant
research. First, prediction can refer to a correlation between two
contemporaneous values, such as height predicting weight.
Second, prediction can refer to the correlation of one variable
in a group at an initial time point to another variable in the
same group at a future time point (an in-sample correlation).
Third, prediction can refer to a generalizable model that applies
to out-of-sample individuals. All studies reviewed here relate an
initial brainmeasure to a future behavioral outcome, and the term
correlation refers to in-sample findings, and the term prediction
refers to out-of-sample generalizations.
Such research can be conceptualized as comprising three
stages, beginningwith within-sample correlations to discover re-
lations of interest, progressing to predictive analyses in which
predictions for individuals are derived from data from other in-
sample individuals, and culminating in predictive analyses in
which a model from one sample is used to predict outcomes
in an independent sample (Figure 1). Each stage requires more
participants, so that prior stages may justify larger-scale studies.
The vastmajority of findings to date are correlational (61 of the 72
reviewed here), but some studies reported predictive analyses
(with only one study having fully independent samples) (Table 1).
The major limitation with correlational analyses reporting the
significance of the overall fit of linear or multiple regression
models to a data set is that findings are tied to the outcome for
a particular group. From a predictive modeling standpoint, the
error from this fit is typically termed the training error, whereas
the error on an unseen data set would be called the test or gener-
alization or prediction error. The training error is always an under-
estimate of the test error. The quality of amodel can be evaluated
by measuring its test error. Minimizing this error is the goal of
building predictionmodels. Oneway to decompose the test error
is to describe it as a sum of training error and optimism (Efron,
2004). Optimism is the difference between the test error, which
is always higher, and the training error.
The most common approach for reducing optimism is to use a
validation set in which some data are set aside to estimate the
test error. In many studies of brain imaging, this limits the amount
of data available for training because of small sample sizes. A
common approach is to use cross-validation, in which one di-
vides a data set into a number of folds. One fold is held aside
as a test set, and data from the remaining folds (training data)
are used to train the model. This model is then applied to the
test set, and the model error is calculated. This procedure is
repeated by considering each fold as a test set. The average er-
ror across the test folds is reported as the generalization error. If
the number of folds equals the number of data points, then only
one data point is held out for testing, and this is known as leave
one out cross-validation. In general, this approach is unbiased
Figure 1. Three Stages of Predictive Model
Identification
(1) Discovery phase. Explore and evaluate asso-
ciations between baseline neuromarkers and
behavioral outcomes.
(2) Cross-validation phase. A cross-validation
routine is used to separate data into training and
test sets. The model is built using training data and
tested on out-of-sample test data. Upon suc-
cessful evaluation of the performance of the model
and features, all data are used to build a prediction
model.
(3) Generalization phase. A prediction model built
via cross-validation is applied to a new data set.
The new data are then used to update the model.
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Rao et al., 2008).
Another practical approach is to randomly split data into
training and test sets (e.g., 10% of the data are in the test set).
The splitting is repeated several times. On each iteration, a
model is fit on the training data and tested on the test data.
This results in a distribution of prediction errors that can provide
a confidence interval for a given application. However, such pro-
cedures can still lead to increased optimism if models are cho-
sen or their parameters are tuned after peeking at the test results
(Koban et al., 2013). Selecting models and their parameters from
cross-validation on the training data can reduce such optimism.
The training data itself can be subjected to cross-validation and
subdivided into training and test sets to determine which model
is best suited for the training data. This procedure is called
‘‘nested cross-validation.’’ Because different models may be
selected for each cross-validation split, the most selected model
might be considered to be the ‘‘best’’ model. A variety of learning
models coupled with cross-validation has been used in brain im-
aging. These range from linear, multiple, and logistic regression
models to approaches such as support vector machines (SVM
[Vapnik, 1999]) or least absolute shrinkage and selection oper-
ator (LASSO [Tibshirani, 1996]), relevance vector machines
(Bishop and Tipping, 2000), and random forests (Breiman, 2001).
The difference between the amount of variability accounted for
by within-sample correlations and out-of-sample predictions is
rarely reported. Two within-sample correlational studies (Aharoni
et al., 2013; Demos et al., 2012) were reanalyzed by a different
investigator (R.A. Poldrack, personal communication), and the
outcome variance accounted for by the generalizable model
was far smaller than that for the within-sample correlation (see
Aharoni et al., 2014). Although inmost cases the predictivemodelNeuronresults in a more conservative outcome
than thecorrelationalmodel, thedifference
varies across data sets. In all cases, how-
ever, predictive analyseswill be necessary
to translate correlational observations into
educational or clinical practice.
Future Learning and Cognitive
Performance in Adults
Variation in initial neuromarkers has been
associated with subsequent learning orcognitive performance, and, in most cases, these variations
occurred in the neural networks associated with the kind of
learning. Larger volumes of the striatum correlated with superior
video game skill learning (Erickson et al., 2010). This correlation
was specific to the dorsal striatum volume, did not extend to the
hippocampus or ventral striatum, and accounted for 23% of the
variance in learning. The importance of the striatum for such skill
learning is consistent with evidence that lesions of the striatum
impair skill learning (e.g., Heindel et al., 1989). Superior word
learning correlated with DTI measures of the left arcuate fascic-
ulus, a white matter pathway connecting major left hemisphere
language regions (Lo´pez-Barroso et al., 2013).
Brain differences in language-related neural systems have
also been related to variation in learning novel speech distinc-
tions not present in a person’s native language. Superior learning
was associated with anatomical differences, specifically greater
asymmetry (left to right) in parietal lobe volumes and higher white
matter density in left Heschl’s gyrus (Golestani et al., 2002,
2007). Larger anatomical structures in the language-dominant
left hemisphere may support the rapid temporal processing
needed to learn novel auditory distinctions that occur critically
in the first 30–50 ms of nonnative language sounds. Resting-
state functional connectivity has also been associated with vari-
ation in auditory language learning. Better learners of a nonnative
speech contrast exhibited greater functional connectivity (corre-
lation) than poor learners between inferior frontal and parietal re-
gions thought to be major components of the left hemisphere
language system (Ventura-Campos et al., 2013; other related
studies are reviewed in Zatorre, 2013).
Neuromarkers have also correlated with musical and visual
learning. For auditory learning of microtonal pitch discrimination
(with intervals smaller than typically used in musical scales),85, January 7, 2015 ª2015 Elsevier Inc. 13
Table 1. Publications Cited in This Article that Used Cross-Validation Techniques to Measure Out-of-Sample Prediction Error
Publication Sample Size Application Cross-Validation Method Learning Model
Whelan et al., 2014 271 future adolescent alcohol misuse 10-fold logistic regression with elastic net
Hoeft et al., 2007 64 future reading skills LOO linear regression
Ullman et al., 2014 62 future working memory capacity LOO nu-SVR
Ball et al., 2014 48 response to CBT in GAD and PD out of bag random forest
Doehrmann et al., 2013 39 SAD stratified K-fold linear regression
Hoeft et al., 2011 25 future reading gains in dyslexia LOO linear SVC
Supekar et al., 2013 24 response to math tutoring 4-fold linear regression
Falk et al., 2010 20 persuasion-induced behavior
change
2-fold linear regression
Siegle et al., 2012 17 (cohort 1)
20 (cohort 2)
response to CBT for depression out of bag random forest
Bach et al., 2013 17 future reading skills LOO discriminant analysis
Costafreda et al., 2009 16 response to CBT for depression LOO PCA + linear SVM
LOO, Leave One Out; nu-SVR, nu-Support Vector Regression; CBT, cognitive behavioral therapy; GAD, generalized anxiety disorder; PD, panic dis-
order; SAD, social anxiety disorder; SVC, Support Vector Classification; PCA, Principal Component Analysis; SVM, Support Vector Machine.
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vation in the bilateral auditory cortex to pitch-interval size ex-
hibited greater learning over a 2-week training period (Zatorre
et al., 2012). The higher slope of activation may reflect a finer-
grained cortical encoding of pitch information that potentiates
more rapid learning during training. People who were better at
learning to make fine visual discriminations had, at baseline,
stronger functional connectivity within portions of the visual cor-
tex and between the visual cortex and prefrontal association
areas (Baldassarre et al., 2012). These regions were also a sub-
set of the regions that were activated by the discrimination task
itself, suggesting that initial individual differences within the task-
evoked neural networks encouraged or discouraged effective
learning.
The studies mentioned above examined variation in learning
across individuals, but individuals also vary across time in their
performance and learning. Two fMRI studies exploited natural
fluctuations in resting-state BOLD signals in an attempt to distin-
guish brain states within an individual that were associated with
superior or inferior performance on vigilance and learning tasks.
In both studies, stimulus presentation was triggered via real-time
fMRI when BOLD signals in relevant brain regions were hypoth-
esized to be in optimal or suboptimal states. In the vigilance task,
an individual had better vigilance (faster reaction times) for the
appearance of an unpredictable visual target when, before the
appearance of the target, the BOLD signal was high in the sup-
plementary motor area (a region associated with motor planning)
and low in components of the default mode network (a network
that is more active during rest than most tasks and that has been
associated with internal self-reflection rather than external
perceptual attention) (Hinds et al., 2013). In the memory task,
an individual exhibited superior learning of scenes when BOLD
signals were lower before the appearance of a scene in the pos-
terior parahippocampal cortex, a region that is selectively
responsive to scenes (Yoo et al., 2012). Therefore, brain states
could be identified that predicted whether an individual was
ready to be vigilant or ready to learn.14 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.Future Learning and Education in Children
Reading and mathematics are the two foundations of education,
and, accordingly, the focus of school curricula from elementary
school through high school. The first major education experience
for children is learning to read in early school years, after which
they use those reading skills to learn all other subjects. Some
children (5%–17%) have developmental dyslexia, which is a
persistent difficulty in learning to read that is not explained by
sensory, cognitive, or motivational factors or lack of adequate
reading instruction (Shaywitz, 1998) and that is highly heritable
(Pennington and Gilger, 1996). The best understood psycholog-
ical cause of dyslexia is a weakness in phonological awareness,
the understanding that spoken words are composed of discrete
sounds (phonemes) that can be mapped onto letters or syllables
(graphemes) (Bradley and Bryant, 1978), although several other
putative causes have been identified (reviewed in Gabrieli, 2009).
Brain measures in infants have correlated with future success
or failure in language and reading years before explicit reading
instruction. Event-related potentials (ERPs), which are time-
locked changes in electrical activity measured with EEG scalp
electrodes, have revealed a risk for future language and reading
difficulties in newborns within hours or days of birth. These
studies typically involve infants from families with a history of lan-
guage or reading difficulty to increase the proportion of infants
who will progress to language and reading difficulty. ERP re-
sponses to speech sounds within 36 hr of birth discriminated
with over 81% accuracy those infants who would go on to
become dyslexic at age 8 (Molfese, 2000). Newborns, tested
within a week of birth, had ERPs in response to speech sounds
that correlated with language scores at 2.5, 3.5, and 5 years of
age (Guttorm et al., 2005).
Some studies have reported that neuroimaging measures
enhance or outperform traditional behavioral measures in fore-
casting children’s reading abilities in future months and years.
One study examined how children 8–12 years of age, identified
by their teachers as struggling readers, fared from the beginning
to the end of a school year in single-word decoding skills (the
Figure 2. Functional and Structural Brain
Measures Predicting Educational
Outcomes
(A and B) fMRI predictor of reading gains in
dyslexia. Greater activation for a phonological task
in the right inferior frontal gyrus (Rt IFG) (A) pre-
dicted greater gains in reading 2.5 years later in
dyslexic children (B). Each red circle is an individ-
ual (based on Hoeft et al., 2011).
(C and D) MRI predictor of math tutoring gains in
students. Greater gray matter volume of the right
(R) hippocampus (C) predicted greater perfor-
mance gains in students after 8 weeks of tutoring
(D). Each blue circle is an individual (from Supekar
et al., 2013).
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grapheme mapping rules) (Hoeft et al., 2007). At the beginning
of the school year, these children were evaluated with over a
dozen behavioral measures of reading and reading-related skills,
an fMRI task requiring rhyme judgments for pairs of printed
words, and a VBM analysis of anatomic gray and white matter
densities. The beginning-of-the-year behavioral measures ac-
counted for 65% of the variance in end-of-year scores, and the
brain measures accounted for 57% of that variance. The combi-
nation of behavioral and brain measures accounted for a signif-
icantly better 81% of the variance, demonstrating enhanced
forecasting of student reading skills across a school year.
Among children with dyslexia, there is considerable variation
in the degree to which individual children do or do not compen-
sate for their reading difficulty by closing the gap between their
actual and age-expected reading skills. A longitudinal study of
older children (mean age of 14 years) examined how behavioral
measures (17 tests of reading and reading-related skills), fMRI
activation for a word-rhyming task, and DTI indices of white
matter organization predicted which children, over the next
2.5 years, would compensate or persist in their reading difficulty
(Hoeft et al., 2011). None of the standard behavioral measuresNeuroncorrelated with future reading gains, but
the brainmeasures did yield such correla-
tions (Figure 2). In combination, greater
activation in the right prefrontal cortex
(a region not typically engaged for
reading single words at this age) and
greater white matter organization of the
right superior longitudinal fasciculus pre-
dicted, with 72% accuracy, whether a
child would be in the compensated or
persistent group. Multivoxel pattern anal-
ysis of whole-brain fMRI activation, a
data-driven pattern classification anal-
ysis, yielded over 90% accuracy in classi-
fyingwhether a dyslexic child, at baseline,
would belong to the compensating or
persistent group 2.5 years later.
Longitudinal studies have also found
neuromarkers associated with future
reading skills in children who were not
selected on the basis of family history orreading difficulty. In a 5-year longitudinal study, an auditory
ERP measure (hemispheric lateralization of late mismatch nega-
tivity) in prereading kindergarteners significantly improved the
forecasting of future reading performance in second, third, and
fifth grades in combination with prereading skills (Maurer et al.,
2009). Only the ERP measure (and not any behavioral measure)
correlated with future reading performance in fifth grade. A visual
ERP study with prereading kindergarteners also reported that
the combination of behavioral measures and both ERP and
fMRI responses to print explained up to 88% of the variance in
second-grade grade reading ability (Bach et al., 2013). These
studies suggest that neuromarkers in prereading kindergar-
teners may enhance the identification of children who will strug-
gle to read even before reading instruction begins in school. This
is important because current reading interventions are most
effective in young, beginning readers, and effective intervention
prior to reading failure may not only be more effective but also
spare children the sense of failure that often accompanies early
struggles in reading.
In older typical readers 9–15 years of age, fMRI activations in
response to a word-rhyming task were associated with nonword
reading skills up to 6 years in the future, with the specific85, January 7, 2015 ª2015 Elsevier Inc. 15
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gan et al., 2011). In younger children, greater activation in brain
regions associated with phonological recoding (e.g., the inferior
frontal gyrus) was associated with greater future reading skill,
whereas, for older children, greater activation in brain regions
associated with orthographic analysis of print (e.g., the fusiform
gyrus) was associated with lesser future gains. These findings
underscore how different developmental stages of learning to
read, perhaps transitioning from a younger gaining of skill in sin-
gle-word decoding (print-to-sound correspondence) to an older
mastering of fluent visual analysis of connected print, may invoke
relatively different components of the brain’s reading circuitry.
There is also considerable variation in how well children can
learn a second language. For native Chinese speakers around
age 10, greater activation in response to English words and non-
words in the left fusiform gyrus and left caudate correlated with
superior English word-reading levels a year later (Tan et al.,
2011). The putative visual word form area, which is highly
responsive to learned print, is located in the left fusiform gyrus
(Dehaene and Cohen, 2011). The leftward lateralization of neuro-
markers may have been related to properties of alphabetic lan-
guages such as English because there is evidence that variation
in microstructural properties of right hemisphere white matter
pathways correlated with initial learning of Mandarin Chinese in
young adults (Qi et al., 2014). The rightward lateralization of neu-
romarkers in native English speakers associated with future suc-
cessful initial language learning may reflect the tonal and visuo-
spatial properties, respectively, of spoken and written Mandarin
Chinese. Therefore, neuromarkers correlated with second lan-
guage learning may vary depending on the kinds of mental re-
sources needed to learn different kinds of languages.
Mathematical problem-solving skills are the foundation of later
performance in science and engineering. Academic skill in arith-
metic relies on multiple cognitive processes, including working
memory, the mental processes that support the maintenance
and manipulation of goal-relevant information over brief time pe-
riods (reviewed in Raghubar et al., 2010). In a longitudinal study,
children 6–16 years of age underwent behavioral testing (work-
ing memory, reasoning, and arithmetical abilities) and fMRI while
performing a visuospatial working memory task (Dumontheil and
Klingberg, 2012). Neuroimaging analyses focused on the intra-
parietal sulcus (IPS), a brain region associated with both visuo-
spatial working memory and numerical representation. The
working memory and reasoning measures were independent
predictors of arithmetical performance 2 years later. The magni-
tude of visuospatial working memory activation in the left IPS
also predicted future arithmetical performance. Combining the
neuroimaging and behavioral data more than doubled the accu-
racy of predicting future mathematical ability compared with the
use of only behavioral data.
The future growth of working memory ability in the same age
range has also been better predicted by a combination of neuro-
imaging and behavioral measures than by behavioral measures
alone (Ullman et al., 2014). Interestingly, although current work-
ing memory capacity correlated with activation in frontal and pa-
rietal regions, future capacity was best predicted by structural
and functional measures of the basal ganglia and thalamus. Spe-
cifically, greater activation in the caudate and thalamus and16 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.greater fractional anisotropy (FA) of surrounding white matter
as measured by DTI predicted future growth in working memory
over the next 2 years.
There is increasing interest in improving the effectiveness of
learning through teaching that takes into account variation
among students. One study examined whether neuromarkers
could identify which children would benefit from a math tutoring
program for third graders (ages 8 and 9) that encouraged stu-
dents to shift from counting to fact retrieval as a basis for an arith-
metic problem-solving strategy (Supekar et al., 2013). Individual
differences in how much students benefitted from the tutoring
program did not correlate with baseline behavioral scores on
tests of intelligence (IQ), working memory, or mathematical abil-
ities. Conversely, at baseline, greater right hippocampal volume
and resting-state intrinsic functional connectivity between the
right hippocampus and prefrontal and striatal regions correlated
with future performance improvements (Figure 2).
Future Criminality
The criminal justice system is rife with demands for predictions of
future behaviors as judgments are made about bail, sentencing,
and parole. The demonstrated inaccuracy of expert clinical judg-
ments (Monahan, 1981) has motivated the use of an actuarial
approach that estimates risk for future antisocial behavior based
on characteristics such as age, sex, criminal history, and drug
use (e.g., Yang et al., 2010). Building on evidence that impulsivity
(behavioral disinhibition) is a major risk factor for recidivism,
brain activations to an impulse control task (go/no-go task)
were examined in 96 male offenders who were then followed
longitudinally (Aharoni et al., 2013). The likelihood that an
offender would be rearrested over a 4-year period doubled
when, at baseline, the offender had low activation in the anterior
cingulate cortex, a region associated with cognitive control and
especially the resolution of cognitive conflict. Although the corre-
lation between baseline brain activation and future rearrest was
significant, there was no or weaker correlation for other predic-
tors (age, scores on a psychopathy checklist, lifetime substance
abuse, or behavioral error rate on the scanner task).
Future Health
Studies have examined whether neuromarkers are related to
future health-related behaviors such as alcohol abuse, drug
abuse, or unhealthy eating. Alcohol use by underage drinkers
is an important public health problem because such use in ado-
lescents is risky and also associated with life-long alcoholism.
Heavy or binge drinking is the primary source of preventable
morbidity and mortality for the more than 6 million American col-
lege students (Wechsler et al., 2002). Early onset of alcohol use
by age 12 is associated with numerous undesirable outcomes in
adolescence (Gruber et al., 1996), and initiation of drinking
before age 15, versus after age 20, quadruples the likelihood of
alcoholism (Grant and Dawson, 1997).
In a longitudinal study, 12- to 14-year-olds with little or no his-
tory of substance abuse performed a go/no-go task of response
inhibition while undergoing fMRI (Norman et al., 2011). About
4 years later, these adolescents were divided into two groups
who did or did not transition to heavy use of alcohol. Widespread
reductions in baseline activation, including in the prefrontal and
Neuron
Reviewanterior cingulate cortices, were found in adolescents who later
transitioned to heavy alcohol use relative to those who did not.
Among adolescents 16–19 years of age with an ongoing history
of substance use disorders, those who exhibited less prefrontal
and greater parietal activation on the same task had higher levels
of substance use over the following 18 months (Mahmood et al.,
2013). Overall, the findings suggest that a relative weakness in
the recruitment of anterior brain regions that aremost associated
with cognitive control of behavior may be a predisposition for
early alcohol use or sustained substance abuse.
Adolescents who exhibited greater activation in response to
monetary reward in the basal ganglia were more likely to engage
in substance use (alcohol and drugs) a year later (Stice et al.,
2013). In contrast, those who were already using substances at
baseline exhibited lesser activation in the basal ganglia at base-
line. These findings indicate that reward systems of the basal
ganglia are also involved in substance abuse but that brain mea-
sures of future risk for substance use may be quite different than
brain measures reflecting the consequence of current use of
substances.
The largest study of future adolescent misuse of alcohol fol-
lowed nearly 700 adolescents and collected detailed histories,
personality measures, genetic information, structural and func-
tional MRI data, and cognitive performance measures (Whelan
et al., 2014). fMRI tasks examined inhibitory control, reward pro-
cessing, and facial expressions of emotion. In 271 of these ado-
lescents, a multidomain analysis was used to predict future
binge drinking. The most robust brain predictors of future binge
drinking came from the right precentral and bilateral superior
frontal gyri, with contributions from several structural (gray mat-
ter volume) and functional (inhibitory control and reward
outcome) features. In the predictive model, these brain mea-
sures were coupled with life events, personality measures, and
an anxiety sensitivity subscale of the substance use risk profile
scale. Any one feature in isolation had only a modest influence
on prediction, and many of the features predicting future misuse
were different from the features dissociating groups of binge
drinkers and nonbinge drinkers. Such a study highlights the mul-
tiple causal factors for substance abuse and the scale of data
needed to predict the future unfolding of such multifaceted pro-
cesses.
Healthy eating to avoid or reduce obesity is also amajor public
health concern. Neuroimaging studies have reported that fMRI
activations in response to food-related pictures forecast future
changes in body mass index (BMI) over the next 6–12 months.
Two studies examined the relation between baseline fMRI acti-
vations and weight gain over the following year in girls identified
as having body image concerns. Activations in response to
palatable food occurred in brain regions associated with reward
anticipation (e.g., regions of basal ganglia) or reward valuation
(e.g., the orbitofrontal cortex). In one case, dopamine-related ge-
netic variation interacted with blunted brain activation to corre-
late with elevated risk for future weight gain (Stice et al., 2010).
In another case, lateral orbitofrontal cortical activation during
initial orientation to appetizing food cues correlated with future
increases in BMI over a 1-year period (but behavioral patterns
of response did not correlate with BMI increases) (Yokum
et al., 2011).Another study demonstrated the specificity of brain activa-
tions to food cues in relation to future weight gain (Demos
et al., 2012).Women arriving at college sawpictures of food, sex-
ual scenes, and control pictures during fMRI. At baseline and
again toward the end of the school year, the women’s weights
and self-reports of sexual behavior were measured. A greater
initial response in the reward-responsive nucleus accumbens
for food pictures correlated with greater BMI gains 6 months
later, whereas a greater initial response to sexual scenes corre-
lated with greater sexual desire and more sexual experiences
6 months later.
In a related study, college-aged women participated in an
fMRI study of brain responses to pictures of food and for
response inhibition on a go/no-go task, followed by experience
sampling via smartphone. Over the course of 1 week, they
were periodically asked to report their desire to eat food, at-
tempts to resist the temptation to eat, and whether or not and
how much they actually ate (Lopez et al., 2014). Greater nucleus
accumbens activation to food pictures correlated with greater
desires for food, more likelihood to give in to the temptation to
eat, and larger amounts eaten. Greater activation of the inferior
frontal gyrus during response inhibition was associated with
reduced surrender to temptation and less eating. Overall, these
studies suggest that an interplay between the response to food
cues that occurs in reward-sensitive striatal and orbitofrontal re-
gions and the response in cognitive control regions of the lateral
prefrontal cortex contributes to future healthy or unhealthy
eating patterns.
Another health-related behavior is the use of sunscreens for
protection against sunburn and some forms of skin cancer. In
one study, participants saw slides communicating the impor-
tance and proper application of sunscreen (Falk et al., 2010).
Participants also reported recent use of, intention to use, and
attitudes toward sunscreen. Greater activation in the medial
prefrontal cortex, a brain region associated with self-refer-
ence, correlated with changes in the use of sunscreen as
measured by an unexpected self-report 1 week later. Brain
measures accounted for about 25% of the change in use of
sunscreen above and beyond self-reported changes in atti-
tudes and intentions following presentation of the health infor-
mation during scanning. Activation in the medial prefrontal
cortex may broadly represent value because the magnitude
of activation in that brain region (and the striatum) in response
to individual consumer goods was associated with subse-
quent preferences for choosing those goods (Levy et al.,
2011).
Some studies have examined how brain function at one point
in time correlates with mental health outcomes at future time
points independent of treatment. For example, greater amyg-
dala activation to emotional facial expressions among patients
with depression correlated with reduced symptoms of depres-
sion 6 month later, controlling for initial depression severity and
medication status (Canli et al., 2005). In a memory paradigm
with negative pictures, greater baseline activation for success-
fully recalled pictures in the posterior cingulate cortex and
medial prefrontal cortex correlated with greater improvement
in depressive symptoms 18 months later (Foland-Ross et al.,
2014).Neuron 85, January 7, 2015 ª2015 Elsevier Inc. 17
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Biomarkers in general, and neuromarkers in particular, are not
used currently to predict treatment response for neuropsychi-
atric disorders despite considerable evidence that any specific
pharmacological or behavioral treatment is likely to be effective
for some patients but ineffective for a considerable number of
other patients. Measurement of treatment efficacy varies, but it
typically involves a patient report or clinician observation, often
via a structured interview or questionnaire. A highly effective
treatment results in remission, the absence of symptoms, or in
a substantial response, defined as an outcome in which the pa-
tient remains somewhat symptomatic but is much improved
(Frank et al., 1991).
Across many neuropsychiatric diagnoses, remission or sub-
stantial response occurs in about 50% of patients for a given
therapy. For depression, cognitive behavioral therapy (CBT) is
effective in 40%–60% of patients (Hollon et al., 2002), and selec-
tive serotonin reuptake inhibitors are effective in 40%–60% of
patients, although many patients who fail to respond to an initial
treatment will respond to another treatment or combination of
treatments (Souery et al., 2006). Similar 40%–60%success rates
for a given pharmacological or behavioral treatment have been
reported for generalized anxiety (Pollack et al., 2003), social anx-
iety disorder (Otto et al., 2000), and attention deficit hyperactivity
disorder (Wender, 1998; Biederman et al., 2010). This variability
in treatment response, which is not understood and not simply a
consequence of disease severity, suggests that there are clini-
cally important neurobiological differences among patients
sharing a diagnostic label so that a specific treatment will be
effective for some but not other patients.
To a remarkable degree, there is an absence of evidence
about which treatment is likely to be effective for a particular pa-
tient. Although patients often do benefit from a second or third
sort of attempted treatment, there is considerable human and
economic cost for delaying effective treatment for patients and
families who are often in crisis. The idea of personalized medi-
cine, that people vary in their response to treatments and that
more effective medicine can be practiced by knowing which
treatment is most likely to benefit a particular patient, has been
associated often with genetics. It seems plausible, however,
that quantitative brain measures may also reveal variation
among patients that provides an evidence-based rationale for
what treatment is most likely to help a particular patient among
currently available treatments.
Future Response to Pharmacological Treatment
Over 20 studies of depression have reported that pretreatment
neuroimaging measures can correlate with or predict clinical
improvement following pharmacological treatment (reviewed in
Pizzagalli, 2011; Fu et al., 2013). In one study, prior to treatment,
reduced subgenual anterior cingulate cortex (ACC) metabolism
was measured by PET in patients who subsequently responded
poorly to medicine relative to either healthy controls or patients
who responded well to medication and who exhibited greater-
than-normal metabolism (Mayberg et al., 1997). No clinical mea-
sure, such as depression severity, or behavioral measure, such
as cognitive performance, distinguished the patients who would
or would not respond to treatment. The subgenual ACC (Brod-
mann area 25) is especially salient for depression because it18 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.has been shown to be functionally and structurally atypical in
depression (Drevets et al., 1997) and has been a target for
deep brain stimulation treatment of depression (Mayberg et al.,
2005).
A meta-analysis of 20 studies on depression supported the
conclusion that increased baseline activation of the ACC, ex-
tending into the orbitofrontal cortex, was associated with better
treatment response but that decreased activation of the insula
and striatumwas also associatedwith better treatment response
(Fu et al., 2013). In an fMRI activation study in which patients
viewed faces with sad facial expressions of varying intensity, a
machine learning approach (SVM and leave one out (LOO)
cross-validation) identified patients who would have remission
with 71% sensitivity/86% specificity (Costafreda et al., 2009).
There is also evidence that structural brain measures at baseline
were associated with treatment outcome. Across studies, a
worse response to treatment has been associated with
decreased gray matter volume in the left dorsolateral prefrontal
cortex and also in the right hippocampus (Fu et al., 2013). Finally,
repetitive transcranial magnetic stimulation (rTMS) is a less com-
mon treatment for depression, but resting-state functional con-
nectivity measures have been associated with clinical response
to such treatment (Salomons et al., 2014). Higher corticocortical
connectivity and lower corticothalamic, corticostriatal, and cor-
ticolimbic connectivity at baseline were associated with better
treatment response.
In an open-label study examining the efficacy of treating
generalized anxiety disorder with venlafaxine, patients viewed
faces with fearful or neutral expressions. Greater activations
for fearful relative to neutral faces in the rostral ACC and lesser
activations for fearful relative to neutral faces in the left amygdala
both correlated with greater clinical improvement (Whalen et al.,
2008). These correlations occurred despite no activation differ-
ences in the rostral ACC or amygdala either between patients
and controls or between pretreatment and posttreatment in pa-
tients who did improve clinically in response to treatment. Such a
finding underscores the idea that neuromarkers that are associ-
ated with treatment response need not reflect the same func-
tions as those related to etiology.
Future Response to Behavioral Treatment
Perhaps the best validated kind of behavioral treatment for
neuropsychiatric disorders is CBT, meta-analyses of which indi-
cate it to be effective for many disorders, including depression,
generalized anxiety disorder, panic disorder, and social anxiety
disorder (e.g., Butler et al., 2006; Hofmann et al., 2012). Multiple
studies have reported that CBT is similarly effective as pharma-
cological treatments for depression (DeRubeis et al., 2005),
generalized anxiety disorder (Mitte, 2005), pediatric anxiety
(Walkup et al., 2008), and social anxiety disorder (Heimberg
et al., 1998). For disorders that are treated primarily with medica-
tions, CBT has been shown to enhance clinical outcome relative
to other augmentations for obsessive-compulsive disorder
(OCD) (Simpson et al., 2013) and schizophrenia (Grant et al.,
2012).
Several neuroimaging studies have reported that pretreatment
neuroimaging measures correlate with or predict the magnitude
of clinical improvement following CBT in unipolar major depres-
sion, schizophrenia, and social anxiety disorder. The initial study
Figure 3. Functional Brain Measure Predicting a Clinical Outcome
Prior to treatment, patients with social anxiety disorder who exhibited greater
posterior activation (left) for angry relative to neutral facial expressions had a
better clinical response to CBT than patients who exhibited lesser activation
(right) (based on Doehrmann et al., 2013).
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occurred in 14 unmedicated patients with depression who
viewed emotionally negative words prior to treatment. Both
less sustained activation in the subgenual ACC and more sus-
tained activation in the amygdala were associated with a greater
improvement in response to CBT (Siegle et al., 2006). The finding
that less sustained activation in the subgenual ACC was associ-
ated with a better future response to CBT was replicated and
extended in a larger study of patients with depression (Siegle
et al., 2012). This study is noteworthy in its use of a model gener-
ated from one cohort being used to predict the outcomes of an
independent cohort.
For patients with schizophrenia being treated pharmacologi-
cally, about half respond beneficially to additional CBT treatment
(e.g., Wykes et al., 2008). In one set of overlapping studies, pa-
tients receiving CBT exhibited clinical improvements relative to
patients who did not receive CBT (Kumari et al., 2009, 2011; Pre-
mkumar et al., 2009). The magnitude of clinical benefit among
the patients receiving 6–8 months of CBT correlated with both
baseline functional and structural measures. Patients who ex-
hibited a stronger activation in the dorsolateral prefrontal cortex
(DLPFC) during performance of a working memory task and who
exhibited stronger DLPFC-cerebellar functional connectivity in
the most demanding condition of the task derived a greater
benefit fromCBT (Kumari et al., 2009). In another fMRI study, pa-
tients read aloud single words, heard either their own or another
person’s voice that was or was not distorted, and then judged
whether they had heard their own voice or that of another (Ku-
mari et al., 2010). Across several contrasts, greater activation
in the left inferior frontal gyrus and lesser inferior parietal and
medial prefrontal deactivation were associated with a greater
CBT benefit. A greater engagement of prefrontal regions in pa-
tients who benefitted more fromCBTmay be related to regulato-
ry processes that can support effective CBT. There has also
been some evidence for separable neuromarkers related to
CBT response for positive symptoms (excess or distorted
normal functions such as hallucinations or delusions) versus
negative symptoms (diminished normal functions such as apathy
or withdrawal) (Premkumar et al., 2009). Importantly, baseline
symptom severity did not correlate with CBT response so that
the neuromarkers provided measures associated with future
CBT benefits that were not clinically evident at baseline.Current behavioral measures poorly predict treatment
outcome in social anxiety disorder, another disorder often
treated with CBT. Prior to CBT, patients viewed angry versus
neutral faces or negative versus neutral scenes during fMRI
(Doehrmann et al., 2013). Consistent with the social nature of
this anxiety disorder, activations in response to scenes were
not associated with treatment outcome, but activations to angry
relative to neutral faces were associated with CBT outcome.
Greater activations in higher-order visual cortices were predic-
tive of a superior treatment outcome (Figure 3). Initial greater
clinical severity accounted for about 12%of the variance in treat-
ment outcome, whereas the combination of baseline neuroimag-
ing and clinical severity accounted for about 40%of the outcome
variance. Similar findings were observed at a less conservative
statistical threshold in prefrontal cortices, and it is possible that
the relations between prefrontal and higher-order visuopercep-
tual cortices may support or constrain the self-regulatory pro-
cesses that are taught in CBT (i.e., that these results revealed
variation in the neural mechanisms that support CBT response
rather than those of social anxiety disorder).
A study of patients with generalized anxiety disorder or panic
disorder aimed to develop measures that might be sensitive to
single-subject responses to treatment (Ball et al., 2014). Patients
saw negative scenes and either maintained or reduced (via reap-
praisal) their emotional response to the scenes. A random forest
classification was used to identify brain regions in which activa-
tions best predicted treatment outcome. There were greater
activations for responders than nonresponders in the hippocam-
pus during the maintenance of negative images and in the ante-
rior insula and superior temporal, supramarginal, and superior
frontal gyri during reappraisal of negative images. The neuroi-
maging measures yielded superior accuracy, sensitivity, and
specificity in identifying individual patients as future responders
or nonresponders to treatment than clinical or demographic vari-
ables. This study provides an example of data-driven analyses
that are predictive even though the specific patterns of activation
are not readily interpretable in a cognitive neuroscience frame-
work.
For OCD, structural measures at baseline have been associ-
ated with variability in response to exposure therapy (Fullana
et al., 2014). A thinner cortex in the left rostral ACC at baseline
was associated with better responses to therapy. This same re-
gion was thinner overall in patients than in controls, so greater
differences from controls were associated with better outcomes.
The neuroanatomical locus is similar to that often observed in
studies of depression outcomes, which raises the possibility
that similar neural mechanisms may support behavioral thera-
pies across diagnoses.
The studies mentioned above examined the relations between
pretreatment neuromarkers and one kind of treatment, such as
CBT, a medication, or rTMS. The relevant choice that must be
made by a patient or physician, however, is not whether to pur-
sue one kind of treatment but, rather, to select among alternative
treatments. Therefore, an important and practical goal is to
examine whether there are differential predictors of effective-
ness for alternative treatments. One study employed PET imag-
ing prior to patients being randomly assigned to a medication
(escitalopram oxalate) or CBT to treat their depression (McGrathNeuron 85, January 7, 2015 ª2015 Elsevier Inc. 19
Figure 4. Treatment-Specific Biomarker Candidates for Treatment of Depression
Mean regional activity values for remitters and nonresponders segregated by treatment (either escitalopram given as escitalopram oxalate or CBT) are plotted for
the six regions showing a significant treatment 3 outcome analysis of variance interaction effect. Regional metabolic activity values are displayed as region/
whole-brain metabolism converted to z scores (from McGrath et al., 2013b).
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tial response to the two treatments, with right anterior insula hy-
pometabolism correlating with future remission to CBT (and poor
medication response) and right anterior insula hypermetabolism
correlating with future remission to medication (but a poor
response to CBT) (Figure 4). Subgenual ACC metabolism was
higher in patients who failed to respond to either treatment
than in patients who remitted from depression (McGrath et al.,
2013a).
Another study with a small number of pediatric patients with
generalized anxiety also found correlations between pretreat-
ment brain functions and treatment outcomes but did not find
differences between behavioral (CBT) and pharmacological
(fluoxetine) treatments. Greater baseline activation of the amyg-
dala to negative facial expressions was associated with better
symptom improvement regardless of treatment type (McClure
et al., 2007).
Future Relapse for Alcohol, Drug Addiction, Smoking,
and Diet
Alcoholism, drug addiction, smoking, and obesity aremajor pub-
lic health problems that share a similar treatment aim, namely
abstinence from a substance that is harmful to the brain and
body. Several studies have examined relations between neuro-
markers and whether individuals abstain successfully or relapse
into their health problems. Generally, these studies examined
patients who recently became abstinent at the initiation or termi-
nation of a treatment program and then followed these patients
over weeks or months to learn which patients continued to
abstain versus those who relapsed. Improved identification of
risk for relapse could support individualized treatment ap-20 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.proaches that vary for those at minimal or maximal risk for
relapse.
At least 60%of patients who seek treatment for an alcohol use
disorder relapse within 6 months following treatment (Maisto
and Connors, 2006; Udo et al., 2009), and there have been
several studies in which baseline brain measures are associated
with future abstinence versus relapse. In two studies of recently
abstinent patients, greater activation of the putamen was asso-
ciated with a greater likelihood of relapse 3 weeks or 3 months
later (Braus et al., 2001; Gru¨sser et al., 2004). Other measures,
such as self-reported intensity of craving, history of intake, or
duration of abstinence before scanning, were not associated
with likelihood of relapse. Both anatomic (Rando et al., 2011)
and regional cerebral blood flow (Noe¨l et al., 2002) studies re-
ported that baseline measures of the medial prefrontal cortex
were associated with likelihood of relapse. Similarly, patients
who relapsed exhibited reduced volumes of the medial and/or
lateral prefrontal cortex (Durazzo et al., 2011; Cardenas et al.,
2011) and reduced white matter FA in frontal regions (Sorg
et al., 2012) relative to patients who sustained abstinence.
Broadly, a greater reward response to alcohol-related stimuli
and lesser strength in cognitive control regions were related to
relapse.
Relapse after treatment occurs at an estimated 50% rate
within a year among individuals with stimulant dependence
who seek treatment (Miller, 1996). Several neuroimaging studies
have reported that neuromarkers can contribute to the identifi-
cation of future abstinence or relapse. One group of patients
with methamphetamine dependence underwent fMRI 3 or
4 weeks after cessation of drug use and near completion of a
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which point about half of the patients had relapsed (Paulus et al.,
2005). During fMRI, participants attempted to either predict
where a stimulus would appear or to simply note that a stimulus
had appeared. None of the multiple sociodemographic, baseline
symptom, or use characteristics predicted relapse, but patients
who would later relapse exhibited a greater activation in multiple
brain regions than those who would not relapse, including the
prefrontal, parietal, and insular cortices. A pattern of activation
across right insular, posterior cingulate, and temporal regions
correctly identified 20 of 22 patients who did not relapse and
17 of 18 patients who did relapse. Other studies have reported
correlations between baseline fMRI activations and future
relapse for cocaine use after 1 week (Prisciandaro et al.,
2013), after a 10-week outpatient program (and a better predic-
tor than subjective reports of craving) (Kosten et al., 2006), and
after an 8-week outpatient program (Brewer et al., 2008; Jia
et al., 2011). Specific locations of activations that correlated
with future relapse varied across these studies, perhaps reflect-
ing differences in experimental paradigms, analyses, or partici-
pants.
Tobacco smoking is the leading preventable cause of death in
the developed world, with one billion tobacco-related deaths
projected for the 21st century (World Health Organization,
2008). Identifying smokers at high risk for relapse could influence
the design of cessation programs to fit with individual risk pro-
files. In one study, adult nicotine-dependent women underwent
fMRI while viewing smoking-related and unrelated pictures
before quitting smoking (Janes et al., 2010). The women then
made an attempt to quit smoking, and prequit measures were
related to subsequent success or failure in smoking cessation.
A greater baseline activation to smoking-related pictures in the
insula correlated with the likelihood of future relapse. The identi-
fication of insula reactivity as a correlate of future relapse is of in-
terest because lesions to the insula in smokers were associated
with reduced smoking that was immediate and without relapse
(Naqvi et al., 2007). Smokers who did not quit successfully also
exhibited reduced functional connectivity between an insula-
containing network and dorsolateral prefrontal cortex and dorsal
ACC, suggesting a weakness in interactions between brain re-
gions associated with smoking desires with regions associated
with cognitive control. A combination of brain functional data
and a behavioral task resulted in 79% accuracy in identifying
smokers who would or would not abstain from smoking. Future
success in quitting smoking has also been associated with
graymatter volumes in cortical and subcortical regions (Froeliger
et al., 2010).
Brain measures may also help identify what sort of information
presented to people aiming to quit smoking are likely to be effec-
tive. Ads aimed at encouraging people about to try to quit smok-
ing were presented during fMRI, and relapse was followed for a
month (Falk et al., 2011). A greater activation in the medial pre-
frontal cortex at baseline was associated with successful quit-
ting. The addition of the brain measures to other measures
(self-reported intentions, self-efficacy, and ability to relate to
the ads) more than doubled the accuracy of a model accounting
for changes in smoking behavior. In another study with a large
number of smokers, increased activation in brain regions associ-ated with self-reference, especially the medial prefrontal cortex,
in response to individually tailored smoking cessation messages
was associatedwith a better probability of quitting 4months later
(Chua et al., 2011).
Healthy eating is a goal for individuals with obesity, and there is
evidence that brain measures at baseline are associated with
short- and long-term outcomes in a weight loss program (Mur-
daugh et al., 2012). Obese individuals viewed high-calorie food
versus control pictures before and after a 12-week weight loss
program, with a 9-month follow-up. Greater baseline activation
in the nucleus accumbens, insula, and ACC in response to
high-calorie food pictures correlated with lesser weight loss after
12 weeks. Further, less successful weight maintenance at
9 months correlated with greater posttreatment activation in
the insula, ventral tegmental area, and other regions. The rele-
vant regions are associated with interoception (insula), reward
(nucleus accumbens and ventral tegmental area), and cognitive
control (anterior cingulate), which are all processes related to di-
etary decisions.
Future Response to Placebos
Positive medical responses to placebo treatments are often
powerful and can rival the effectiveness of active treatments,
such as medicines for depression (e.g., Walsh et al., 2002).
Consequently, exploitation of placebo mechanisms may offer a
safe therapeutic approach for some patients, but there is evi-
dence for considerable variation in response to placebos (Walsh
et al., 2002). Most studies of the brain basis of individual differ-
ences in placebo responses have focused on pain, in part
because cortical and subcortical brain regions involved in pain
have been relatively well characterized. Placebo analgesia (the
positive influence of a placebo on experienced pain) was related
to a pattern of increased activation in several cortical control re-
gions and decreased activation in somatosensory activation dur-
ing the anticipation of pain rather than activation during reported
analgesia to pain itself (Wager et al., 2011). Patients with a better
future response to placebo treatments exhibited lesser resting-
state functional connectivity between the medial prefrontal cor-
tex and insula during a pain-rating task (Hashmi et al., 2012).
Furthermore, greater network efficiency during the resting state
was associated with a better response to future psychologically
mediated analgesia related to treatment for chronic knee pain
(Hashmi et al., 2014). A range of other findings also indicates
that functional and structural brain measures may help identify
individual patients most likely to benefit from placebo treatments
(reviewed by Koban et al., 2013).
Predicting Individual Futureswith Neuromarkers: Hopes
and Challenges
As reviewed above, neuromarkers obtained from noninvasive
brain imaging have shown great promise for identifying children
and adults more likely to learn well or poorly in particular
domains; more likely to progress to unhealthy (or even criminal)
behaviors; and more likely to respond to particular pharmaco-
logical, behavioral, or placebo treatments for many neurodeve-
lopmental and neuropsychiatric disorders. Although the
amount of scientific evidence is modest in many areas (with
reading and depression having perhaps the greatest concen-
trations of studies to date), there are also numerous studiesNeuron 85, January 7, 2015 ª2015 Elsevier Inc. 21
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significantly enhance traditional measures of individual vari-
ability, such as self-reports, clinical rating scales, or scores
on educational or neuropsychological tests. It is these kinds
of studies that express both a practical and humanitarian pos-
sibility of improving lives through recognizing individual differ-
ences in brain function and structure that greatly influence
the diversity of educational and clinical outcomes and using
that recognition to individually optimize educational and clinical
practices.
Because of these hopes, the challenges of translating cogni-
tive neuroscience measures into better futures for people need
to be carefully identified and thoughtfully overcome. First,
many of the reviewed studies were performed with relatively
small samples, and, in particular, many of the older studies
used statistical approaches that were overly liberal by current
standards. Although such pioneering studies must often begin
with modest resources because it is their outcomes that justify
larger studies, the translation of such science to practical appli-
cation now requires larger studies that can support more
rigorous statistics. This is particularly true for studies of neurodi-
versity that focus on individual differences because there must
be adequate sampling not only of a population as a whole but
also of the diversity of individuals within that population. Second,
studies must mature from correlations between baseline mea-
sures and clinical or educational outcomes to predictive models
that apply the outcomes from one group (training set) to another
group (test set) and, finally, to an individual. This is essential
because use of such measures must operate with new individ-
uals for whom a clinical or educational intervention is being
planned. Third, few studies have integrated findings across mul-
tiple imaging modalities, even when the multiple brain measures
could be made during a single MRI session. Combining multiple
kinds of neuromarkers may enhance their predictive accuracy.
Fourth, it will be important for future studies to involve plausible,
alternative interventions (e.g., McGrath et al., 2013b) because
the question is less often whether a person should receive help
but, rather, which kind of help is most likely to rapidly improve
the person’s education, skills, or health.
Neuromarkers will be useful to the extent that they outper-
form, alone or in combination with traditional measures, mea-
sures that are otherwise available. Indeed, multiple studies
have reported such value from neuromarkers, but other studies
have not examined whether the neuromarkers significantly
improve predictions above and beyond readily available mea-
sures. All forms of brain and behavioral assessment improve
over time, and perhaps a new behavioral assessment will
outperform neuromarkers in the near or distant future. At the
same time, behavioral assessments in many educational and
clinical areas have been developed and maintained over many
years, so it is unknown when breakthroughs might occur.
Perhaps neuroimaging measures will also be useful tools in
developing a new generation of brain-validated behavioral as-
sessments that can be readily used in schools, hospitals, and
medical offices. At the conceptual limit, there ought to be a
strong relation between measures of mind and brain so that a
new generation of behavioral measures could capitalize on the
novel insights of neuroimaging.22 Neuron 85, January 7, 2015 ª2015 Elsevier Inc.If neuroimaging remains necessary for optimal prediction,
there could be concerns about the cost and availability of
MRIs or other measures. In this regard, the cost of MRI imag-
ing in particular has raised concerns about its potential wider
use. One solution for availability could be to use more trans-
portable technologies, such as wireless EEG devices, with
assessment paradigms developed through coupled MRI and
EEG studies. Any economic analysis, however, ought to
include the costs of current practices in which patients are
often inadvertently directed to treatments that turn out to be
ineffective for that patient (often around half of patients for a
given treatment in many cases) or in which children must
demonstrate academic failure before receiving educational
intervention. The cost of a neuropsychological assessment
and report for an individual child or adult, for example, often
exceeds that of an MRI.
If neuromarkers are proven to enhance prediction, there will be
ethical and societal issues to consider. Because of their biolog-
ical nature, brain measures can be overly valued and potentially
divert public and scientific interest in behavioral and social fac-
tors (Kagan, 2013). If neuromarkers become more useful, they
will provoke questions about how to most ethically use predic-
tive information to help people rather than simply select people
most likely to succeed. This important concern, however, must
be weighed against the questionable validity of many current
practices, such as the finding that parole decisions made by
experienced judges appear to be greatly influenced by the
time of day and proximity to a meal at which a case is reviewed
(Danziger et al., 2011) or that medical schools continue to
conduct interviews for admissions despite evidence that deci-
sions based on such interviews have no correlation with objec-
tive measures of medical school performance (DeVaul et al.,
1987; Milstein et al., 1981). For in-patient treatments for sub-
stance abuse, there is little scientific justification for the proto-
typical 28-day treatment period. Even an imperfect predictive
measure of relapse may lead to more rational treatment dura-
tions that are related to individual variation. Neuromarkers and
neuroprognosis may offer practical and valuable contributions
because so many current educational and medical decisions
occur in the absence of scientific evidence that can guide those
decisions.
This review considered mostly studies with relatively short-
term longitudinal educational and clinical outcomes, but future
research may also attempt to predict longer-term outcomes.
Educational and medical practices often respond to crisis,
such as failure in learning to read or coping with depression.
Longer-term research may examine whether neuromarkers
can help identify children at early risk with the hopes of divert-
ing those children away from a trajectory toward failure and
crisis, such as ongoing studies attempting to identify whether
infants at familial risk for autism will or will not progress to
autism over the next few years (Bosl et al., 2011; Wolff
et al., 2012). Such early predictions may require novel forms
of intervention (e.g., language learning remediation in 2- or
3-year-olds that minimizes their difficulty in learning to read
as 5- and 6-year-olds) with the hope that such children never
experience the crises as children or adults that now initiate
intervention.
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